Search

everythinglearnresearchcommunity

for

Search:↓

White hirsute women with PCOS have higher insulin resistance, but similar nitric oxide and fibrinogen levels compared to those with idiopathic hirsutism.

Women with PCOS have higher 5alpha-reductase activity, affecting steroid levels.

Men with early hair loss may have higher insulin resistance and should be checked for related health issues.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Human hair follicles have a unique metabolism that changes between growth stages and may contribute to baldness.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Adequate testosterone is crucial for men's health and quality of life, but its decline with age needs more research.

Young Czech women with PCOS have a higher risk of heart problems and should be regularly checked for cholesterol and glucose issues.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Over half of the adult women with acne in the study had higher than normal levels of male hormones, especially DHEA.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.